Insider Transactions Reported by 9 Insiders of RELMADA THERAPEUTICS, INC.

Symbol
RLMD on Nasdaq
Location
Coral Gables, FL

Insiders trading volume in the past year

RELMADA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sergio Traversa Chief Executive Officer, Director $5,356,000 +$1,065,608 +25% 12 Dec 2025
Maged Shenouda Chief Financial Officer $3,296,000 +$1,245,268 +61% 12 Dec 2025
Paul Kelly COO, Director $1,105,049 +$284,060 +35% 12 Dec 2025
Chuck Ence CA and CO $888,648 +$402,530 +83% 12 Dec 2025
Cedric O'Gorman Chief Medical Officer $32,185 23 May 2023
ERIC THOMAS SCHMIDT Director 25 May 2023
CHARLES J. CASAMENTO Director 12 Dec 2025
Fabiana Fedeli Director 12 Dec 2025
John Glasspool Director 12 Dec 2025

Recent Insider Transactions by Companies or Individuals for RELMADA THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.